Researched for its role in cellular energy (ATP production) and metabolic efficiency, this option can be administered through injections or IV for optimal bioavailability
Those signals are clinically significant, but retatrutide remains investigational and is not a routine prescription option outside clinical trials
Using GLP-1s specifically for weight loss is a slightly newer concept, though, with the first (Saxenda) approved by the FDA in 2014
Further, these investigational agents are targeting a range of pathological mechanisms including protein homeostasis and neuroinflammation
Sermorelin, while less potent, offers broader benefits, including muscle growth, anti-aging effects, and overall GH optimization, at a more affordable price